Related Experiment Video

Updated: Aug 30, 2026

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
10:03

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty

Published on: January 28, 2020

Adrenomedullin expression in coronary circulation after stent implantation as a prognostic factor for restenosis

Yukihiro Hojo1, Uichi Ikeda, Osamu Mizuno

  • 1Division of Cardiovascular Medicine, Jichi Medical School, Tochigi, Japan.

International Journal of Cardiovascular Interventions
|November 25, 2003
PubMed

Insights

Adrenomedullin (AM) levels rise in coronary blood after stent implantation, indicating inflammation. This rise correlates with restenosis, suggesting AM

Area of Science:

  • Cardiovascular Medicine
  • Interventional Cardiology
  • Biomarkers in Heart Disease

Background:

  • Ischemic heart disease (IHD) poses a significant global health burden.
  • Coronary stent implantation is a common intervention for IHD.
  • Restenosis remains a clinical challenge after stenting.

Purpose of the Study:

  • To investigate changes in adrenomedullin (AM) expression in coronary circulation post-stent implantation.
  • To explore the relationship between AM levels and restenosis after stenting.

Main Methods:

  • Blood sampling from the coronary sinus and femoral artery before, immediately after, and 4 hours after stent implantation.
  • Plasma adrenomedullin (AM) level quantification.
  • Correlation analysis between AM levels and late loss index (LLI) at 6 months.

Main Results:

  • Significantly increased AM levels observed in coronary sinus blood 4 hours post-stent implantation.
  • No significant changes in AM levels detected in femoral arterial blood.
  • Positive correlation found between post-procedure coronary sinus AM levels and 6-month LLI.

Conclusions:

  • Inflammation following coronary stent implantation induces adrenomedullin (AM) expression.
  • AM may play a crucial role in the development of restenosis after coronary stenting.

More Related Videos

A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis04:30

A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis

Published on: May 14, 2013

A Modified Two Kidney One Clip Mouse Model of Renin Regulation in Renal Artery Stenosis08:21

A Modified Two Kidney One Clip Mouse Model of Renin Regulation in Renal Artery Stenosis

Published on: October 26, 2020

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...